Maria C. Katapodi

ORCID: 0000-0003-3903-3750
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening
  • Family Support in Illness
  • Genomics and Rare Diseases
  • Genetic factors in colorectal cancer
  • Cancer survivorship and care
  • Palliative Care and End-of-Life Issues
  • Nutrition, Genetics, and Disease
  • Prenatal Screening and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer-related cognitive impairment studies
  • Cancer Risks and Factors
  • Childhood Cancer Survivors' Quality of Life
  • Breast Cancer Treatment Studies
  • Climate Change Communication and Perception
  • Patient-Provider Communication in Healthcare
  • Colorectal Cancer Screening and Detection
  • Health Systems, Economic Evaluations, Quality of Life
  • Lymphatic System and Diseases
  • Ethics and Legal Issues in Pediatric Healthcare
  • Family and Patient Care in Intensive Care Units
  • Dementia and Cognitive Impairment Research
  • Ethics in Clinical Research
  • Family Caregiving in Mental Illness
  • Patient Dignity and Privacy

University of Basel
2016-2025

University Hospital of Basel
2025

University of Wisconsin–Madison
2023

University of Applied Sciences and Arts of Southern Switzerland
2021

University of Michigan–Ann Arbor
2010-2020

Michigan State University
2014

University of North Carolina at Chapel Hill
2014

American Society of Clinical Oncology
2013

Johns Hopkins University
2013

Sidney Kimmel Comprehensive Cancer Center
2013

BackgroundThe challenges of advanced cancer have health implications for patients and their family caregivers from diagnosis through end life. The nature the patient/caregiver experience suggests that mental physical may be interdependent, but limited empirical evidence exists.

10.1007/s12160-015-9743-y article EN Annals of Behavioral Medicine 2015-10-21

PURPOSE To update the ASCO guideline on pharmacologic interventions for breast cancer risk reduction and provide guidance clinical issues that arise when deciding to use endocrine therapy reduction. METHODS An Expert Panel conducted targeted systematic literature reviews identify new studies. RESULTS A randomized trial evaluated of anastrozole estrogen receptor–positive cancers in postmenopausal women at increased developing provided predominant basis update. UPDATED RECOMMENDATIONS In risk,...

10.1200/jco.19.01472 article EN Journal of Clinical Oncology 2019-09-03

Most programs addressing psychosocial concerns of cancer survivors are in-person that expensive to deliver, have limited availability, and seldom deal with caregivers' concerns.This study examined the feasibility translating an efficacious nurse-delivered program (FOCUS Program) for patients their caregivers a tailored, dyadic Web-based format. Specific aims were (1) test preliminary effects intervention on patient caregiver outcomes, (2) examine participants' satisfaction, (3) determine...

10.1097/ncc.0000000000000159 article EN Cancer Nursing 2014-06-19

Abstract Background Comprehensive breast cancer risk prediction models enable identifying and targeting women at high-risk, while reducing interventions in those low-risk. Breast used clinical practice have low discriminatory accuracy (0.53–0.64). Machine learning (ML) offers an alternative approach to standard modeling that may address current limitations improve of tools. The purpose this study was compare the ML-based estimates against a pair established methods—the Cancer Risk Assessment...

10.1186/s13058-019-1158-4 article EN cc-by Breast Cancer Research 2019-06-20
William P. Weber Jane Shaw Andrea L. Pusic Lynda Wyld Monica Morrow and 86 more Tari A. King Zoltán Mátrai Jörg Heil Florian Fitzal Shelley Potter Isabel T. Rubio Maria João Cardoso Oreste ­Gentilini Viviana Galimberti Virgilio Sacchini Emiel J. Rutgers John R. Benson Tanir M. Allweis Martin Haug Régis Resende Paulinelli Tibor Kovács Yves Harder Bahadır M. Gūllūoḡlu Eduardo González Andreé Faridi Elisabeth Elder Peter Dubsky Jens‐Uwe Blohmer Vesna Bjelic‐Radisic Mitchel Barry Susanne Dieroff Hay Kimberly Bowles James French Roland Reitsamer Rupert Koller Peter Schrenk Daniela Kauer-Dorner Jorge Villanova Biazús Fabrício Brenelli Jaime Letzkus Ramon Saccilotto Sarianna Joukainen Susanna Kauhanen Ulla Karhunen‐Enckell Juergen Hoffmann Ulrich Kneser Thorsten Kühn Michalis Kontos Ekaterini Christina Tampaki Moshe Carmon Tal Hadar Giuseppe Catanuto Carlos A. Garcia‐Etienne Linetta B. Koppert Pedro Gouveia Jesper Lagergren Tor Svensjö Nadia Maggi Elisabeth A. Kappos Fabienne D. Schwab Liliana Castrezana Daniel Steffens Janna Krol Christoph Tausch Andreas R. Günthert Michael Knauer Maria C. Katapodi Susanne Bucher Nik Hauser Christian Kurzeder Rosine Mucklow Pelagia G. Tsoutsou Atakan Sezer Güldeniz Karadeniz Çakmak Hasan Karanlık Patricia Fairbrother László Romics Giacomo Montagna Cı́cero de Andrade Urban Melanie Walker Silvia Formenti Guenther Gruber Frank Zimmermann Daniel R. Zwahlen Sherko Küemmel Mahmoud El‐Tamer Marie Jeanne Vrancken Peeters Orit Kaidar‐Person Michael Gnant Philip Poortmans Jana de Boniface

Demand for nipple- and skin- sparing mastectomy (NSM/SSM) with immediate breast reconstruction (BR) has increased at the same time as indications post-mastectomy radiation therapy (PMRT) have broadened. The aim of Oncoplastic Breast Consortium initiative was to address relevant questions arising this clinically challenging scenario.A large global panel oncologic, oncoplastic reconstructive surgeons, patient advocates oncologists developed recommendations clinical practice in an iterative...

10.1016/j.breast.2022.03.008 article EN The Breast 2022-03-18

Purpose/Objectives: To examine the relationship between women's reported social support and their adherence to recommended breast cancer screening guidelines.

10.1188/02.onf.845-852 article EN Oncology nursing forum 2002-01-01

Efforts are needed across disciplines to close disparities in genomic healthcare. Nurses the most numerous trained healthcare professionals worldwide and can play a key role addressing continuum of care. ACCESS is an empirically-based theoretical framework guide clinical practice order ameliorate disparities.

10.3389/fgene.2023.1337366 article EN cc-by Frontiers in Genetics 2024-01-08

Purpose/Objectives: To describe perceived breast cancer risk, identify the percentage of women with inaccurate risk perceptions, and examine influence objective on screening behavior.

10.1188/09.onf.306-314 article EN Oncology nursing forum 2009-04-28

Objective Fear of cancer recurrence, although distinct from distress continues to be under-evaluated, captured, or treated when standard scales are used assess concerns survivors. We tested a model assessing the association demographic and clinical factors, illness representations, perceived risk with fear recurrence in breast Methods recruited 117 survivors at least one year after completing treatment Internet discussion boards for this cross-sectional, descriptive, correlational study....

10.1002/pon.4143 article EN Psycho-Oncology 2016-05-04

The Oncology Nursing Society (ONS) developed its first Research Agenda in 2001 and has updated the agenda every four years. dual purpose of ONS is to determine priority topics for research consistent with mission promote excellence oncology nursing quality cancer care provide Foundation data needed support decision-making process funding research. identified content leaders experts from membership 2014–2018 Project Team.

10.1188/15.onf.450-465 article EN Oncology nursing forum 2015-09-01

Introduction Up to one-fifth of breast cancer survivors will develop chronic cancer-related lymphoedema (BCRL). To date, complex physical decongestion therapy (CDT) is the gold standard treatment. However, it mainly symptomatic and often ineffective in preventing BCRL progression. Lymphovenous anastomosis (LVA) vascularised lymph node transfer (VLNT) are microsurgical techniques that aim restore lymphatic drainage. This international randomised trial aims evaluate advantages interventions...

10.1136/bmjopen-2024-090662 article EN cc-by-nc-nd BMJ Open 2025-02-01

Abstract Background The clinical utility of machine-learning (ML) algorithms for breast cancer risk prediction and screening practices is unknown. We compared classification lifetime based on ML the BOADICEA model. explored differences in their impact practices. Methods used three different model to estimate a sample 112,587 individuals from 2481 families Oncogenetic Unit, Geneva University Hospitals. Performance was evaluated using area under receiver operating characteristic (AU-ROC)...

10.1038/s41416-020-0937-0 article EN cc-by British Journal of Cancer 2020-06-21

Low uptake of genetic services among members families with hereditary breast and ovarian cancer (HBOC) suggests limitations proband-mediated communication risk. This study explored how information proceeds from healthcare providers to probands relatives, the probands' perspectives. Using a grounded-theory approach, we analyzed narrative data collected individual interviews focus groups sample 48 women identified as carriers HBOC-associated pathogenic variants three linguistic regions...

10.3390/jpm12081249 article EN Journal of Personalized Medicine 2022-07-29
Coming Soon ...